Maria Gebre‐Medhin

540 total citations
18 papers, 371 citations indexed

About

Maria Gebre‐Medhin is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maria Gebre‐Medhin has authored 18 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Otorhinolaryngology, 9 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maria Gebre‐Medhin's work include Head and Neck Cancer Studies (13 papers), Head and Neck Surgical Oncology (5 papers) and Salivary Gland Tumors Diagnosis and Treatment (4 papers). Maria Gebre‐Medhin is often cited by papers focused on Head and Neck Cancer Studies (13 papers), Head and Neck Surgical Oncology (5 papers) and Salivary Gland Tumors Diagnosis and Treatment (4 papers). Maria Gebre‐Medhin collaborates with scholars based in Sweden and Germany. Maria Gebre‐Medhin's co-authors include Håkan Wennbo, Per Nilsson, Lars‐Gunnar Kindblom, Jan Törnell, Jeanne M. Meis‐Kindblom, Elisabeth Kjellén, Karin Dillner, Gunnel Hellgren, Håkan Billig and Björn Carlsson and has published in prestigious journals such as Journal of Clinical Oncology, Endocrinology and American Journal Of Pathology.

In The Last Decade

Maria Gebre‐Medhin

16 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Gebre‐Medhin Sweden 9 130 122 113 96 80 18 371
Guang‐Yan Yu China 10 66 0.5× 44 0.4× 70 0.6× 12 0.1× 135 1.7× 32 353
Navin Niles Australia 12 42 0.3× 61 0.5× 126 1.1× 193 2.0× 72 0.9× 13 394
Katsuya Matsuda Japan 12 14 0.1× 39 0.3× 92 0.8× 90 0.9× 105 1.3× 45 406
P. J. Cagnoni United States 10 27 0.2× 90 0.7× 151 1.3× 12 0.1× 34 0.4× 16 312
Anne V. Spedding United Kingdom 14 22 0.2× 76 0.6× 119 1.1× 9 0.1× 66 0.8× 25 394
Jochen B. Bader Germany 7 29 0.2× 34 0.3× 20 0.2× 196 2.0× 32 0.4× 8 407
Donn Young United States 6 86 0.7× 32 0.3× 103 0.9× 7 0.1× 157 2.0× 7 348
Daniela Paccagnella Italy 8 154 1.2× 81 0.7× 150 1.3× 4 0.0× 84 1.1× 11 361
Isao Asakawa Japan 15 11 0.1× 399 3.3× 86 0.8× 20 0.2× 98 1.2× 60 575
Yinong Niu China 12 10 0.1× 199 1.6× 65 0.6× 29 0.3× 143 1.8× 52 444

Countries citing papers authored by Maria Gebre‐Medhin

Since Specialization
Citations

This map shows the geographic impact of Maria Gebre‐Medhin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Gebre‐Medhin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Gebre‐Medhin more than expected).

Fields of papers citing papers by Maria Gebre‐Medhin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Gebre‐Medhin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Gebre‐Medhin. The network helps show where Maria Gebre‐Medhin may publish in the future.

Co-authorship network of co-authors of Maria Gebre‐Medhin

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Gebre‐Medhin. A scholar is included among the top collaborators of Maria Gebre‐Medhin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Gebre‐Medhin. Maria Gebre‐Medhin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Gebre‐Medhin, Maria, Gabriel Adrian, Per Engström, et al.. (2025). Chemoradiation therapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer—Mature Results of the ARTSCAN III Trial. International Journal of Radiation Oncology*Biology*Physics. 123(3). 681–690.
2.
Engström, Per, et al.. (2025). Adaptive radiotherapy in locally advanced head and neck cancer: The importance of reduced margins. Physics and Imaging in Radiation Oncology. 33. 100696–100696. 1 indexed citations
3.
Adrian, Gabriel, Maria Gebre‐Medhin, & Per Nilsson. (2023). Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors. Acta Oncologica. 62(11). 1375–1383.
4.
5.
Adrian, Gabriel, Henrik Carlsson, Elisabeth Kjellén, et al.. (2022). Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy. Radiation Oncology. 17(1). 107–107. 9 indexed citations
6.
Gebre‐Medhin, Maria, et al.. (2022). Hypoxia in relationship to tumor volume using hypoxia PET-imaging in head & neck cancer – A scoping review. Clinical and Translational Radiation Oncology. 36. 40–46. 15 indexed citations
7.
Högmo, Anders, Helena Sjödin, Maria Gebre‐Medhin, et al.. (2021). A national study of health‐related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma. Head & Neck. 43(12). 3843–3856. 6 indexed citations
8.
Gebre‐Medhin, Maria, Eva Brun, Per Engström, et al.. (2020). ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer. Journal of Clinical Oncology. 39(1). 38–47. 98 indexed citations
9.
Adrian, Gabriel, Maria Gebre‐Medhin, Elisabeth Kjellén, et al.. (2020). Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer: Subgroup analysis of ARTSCAN‐trial. Head & Neck. 42(8). 2099–2105. 9 indexed citations
10.
Bengtsson, Martin, et al.. (2020). Mandibulotomy access to tumour sites: fewer complications for postoperative compared with preoperative radiotherapy. International Journal of Oral and Maxillofacial Surgery. 50(7). 851–856. 3 indexed citations
11.
Holmberg, Erik, Jan Nyman, Anders Högmo, et al.. (2020). Swedish National Multicenter Study on Head and Neck Cancer of Unknown Primary: Prognostic Factors and Impact of Treatment on Survival. International Archives of Otorhinolaryngology. 25(3). e433–e442. 8 indexed citations
12.
Högmo, Anders, Helena Sjödin, Maria Gebre‐Medhin, et al.. (2020). Health‐related quality of life among tonsillar carcinoma patients in Sweden in relation to treatment and comparison with quality of life among the population. Head & Neck. 42(5). 860–872. 3 indexed citations
13.
Zackrisson, Björn, Pia Nilsson, Elisabeth Kjellén, et al.. (2019). OC-005 Preoperative vs. postoperative radiotherapy in treatment of oral cavity cancer - The ARTSCAN 2 study. Radiotherapy and Oncology. 132. 6–6. 1 indexed citations
14.
Gebre‐Medhin, Maria, et al.. (2016). Dose-volume analysis of radiation-induced trismus in head and neck cancer patients. Acta Oncologica. 55(11). 1313–1317. 25 indexed citations
15.
Petersson, Kristoffer, Maria Gebre‐Medhin, Crister Ceberg, et al.. (2014). Haematological toxicity in adult patients receiving craniospinal irradiation – Indication of a dose-bath effect. Radiotherapy and Oncology. 111(1). 47–51. 18 indexed citations
16.
Lindgren, Gustaf, Lars Ekblad, Johan Vallon‐Christersson, et al.. (2014). Erythropoietin suppresses the activation of pro-apoptotic genes in head and neck squamous cell carcinoma xenografts exposed to surgical trauma. BMC Cancer. 14(1). 648–648. 4 indexed citations
17.
Gebre‐Medhin, Maria, Lars‐Gunnar Kindblom, Håkan Wennbo, Jan Törnell, & Jeanne M. Meis‐Kindblom. (2001). Growth Hormone Receptor Is Expressed in Human Breast Cancer. American Journal Of Pathology. 158(4). 1217–1222. 80 indexed citations
18.
Ling, Charlotte, Gunnel Hellgren, Maria Gebre‐Medhin, et al.. (2000). Prolactin (PRL) Receptor Gene Expression in Mouse Adipose Tissue: Increases during Lactation and in PRL-Transgenic Mice1. Endocrinology. 141(10). 3564–3572. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang‐Yan Yu Breakdown of academic impact, for papers by Navin Niles Breakdown of academic impact, for papers by Katsuya Matsuda Breakdown of academic impact, for papers by P. J. Cagnoni Breakdown of academic impact, for papers by Anne V. Spedding Breakdown of academic impact, for papers by Jochen B. Bader Breakdown of academic impact, for papers by Donn Young Breakdown of academic impact, for papers by Daniela Paccagnella Breakdown of academic impact, for papers by Isao Asakawa Breakdown of academic impact, for papers by Yinong Niu
Rankless by CCL
2026